https://www.selleckchem.com/pr....oducts/nivolumab.htm
To explore the value of neutrophil count to albumin ratio (NAR) in predicting the outcomes of patients with HBV-associated decompensated cirrhosis (HBV-DeCi). One hundred and fifty-four HBV-DeCi patients were enrolled. The 30-day mortality was determined. Multivariate analysis was applied to identify risk factors for poor outcomes. Receiver operating characteristic curve analyses was performed to evaluate prognostic accuracy. The 30-day mortality was 10.4%. NAR was significantly higher in non-survivors than in survivors and was an ind
Like
Comment
Share
